Mechanism of action of macrophage polarization in non-neoplastic liver diseases and related targeted therapies
10.3969/j.issn.1001-5256.2022.11.042
- VernacularTitle:巨噬细胞极化在非肿瘤性肝脏疾病中的作用机制及其靶向治疗
- Author:
Weiyu CHEN
1
;
Xiaobin QIN
1
;
Yingyu LE
1
;
Han WANG
1
;
Xiaorong LONG
1
;
Dewen MAO
2
Author Information
1. Graduate School of Guangxi University of Chinese Medicine, Nanning 530001, China
2. Department of Hepatology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
- Publication Type:Reviews
- Keywords:
Liver Diseases;
Macrophage Activation;
Pathologic Processes;
Immunotherapy
- From:
Journal of Clinical Hepatology
2022;38(11):2649-2653
- CountryChina
- Language:Chinese
-
Abstract:
Macrophages, as important immune cells, are involved in the key processes that maintain the homeostasis of intrahepatic microenvironment. Recent studies have shown that different liver diseases can induce macrophage polarization (MPP) and form M1 and M2 phenotypes with mutual antagonism. The former promotes the clearance of pathogens and inhibits tumor progression, while the latter exerts an anti-inflammatory effect and promotes tissue repair. However, there are significant differences in the mechanism of action and phenotypic switching of MPP in different liver diseases or at different pathological stages of the disease. This article focuses on the origin and polarization characteristics of intrahepatic macrophages and summarizes the research advances in the role of MPP in the pathogenesis and therapeutic drugs of non-neoplastic liver diseases such as viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, and liver fibrosis, in order to explore the potential of MPP in regulating the immune response and inflammatory response of liver diseases.
